数字乳腺体层合成在女性青年期乳腺癌筛查中的应用及研究进展

doi:10.16150/j.1671-2870.2021.03.012

摘要/Abstract

中图分类号:

R737.9

陶志远, 史春颖, 张琦, 宋富贵, 吕哲昊. 数字乳腺体层合成在女性青年期乳腺癌筛查中的应用及研究进展[J]. 诊断学理论与实践, 2021, 20(03): 294-297.

参考文献 30

[1]	DeSantis CE, Ma J, Goding Sauer A, et al. Breast cancer statistics, 2017, racial disparity in mortality by state[J]. CA Cancer J Clin, 2017, 67(6):439-448. doi: 10.3322/caac.21412 URL
[2]	Paluch-Shimon S, Cardoso F, Partridge AH, et al. ESO-ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women(BCY4)[J]. Ann Oncol, 2020, 31(6):674-696. doi: 10.1016/j.annonc.2020.03.284 pmid: 32199930
[3]	郑荣寿, 孙可欣, 张思维, 等. 2015年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志, 2019, 41(1):19-28.
[4]	Chen HL, Zhou MQ, Tian W, et al. Effect of age on breast cancer patient prognoses: a population-based study using the SEER 18 database[J]. PLoS One, 2016, 11(10):e0165409. doi: 10.1371/journal.pone.0165409 URL
[5]	艾勇彪, 张丹峰, 李文仿, 等. 青年和老年乳腺癌病理特征及预后差异的分析[J]. 现代肿瘤医学, 2018, 26(23):3764-3767.
[6]	陈艳宇, 周扬帆, 彭芳, 等. 青年乳腺癌临床病理特点分子分型及预后分析[J]. 中国妇幼保健, 2021, 36(8):1712-1714.
[7]	代晓倩, 张伟. 致密型乳腺内病变影像诊断研究进展[J]. 中国医药, 2019, 14(7):1107-1110.
[8]	Asbeutah AM, Brindhaban A, AlMajran AA, et al. The effect of different exposure parameters on radiation dose in digital mammography and digital breast tomosynthesis: A phantom study[J]. Radiography(Lond), 2020, 26(3):e129-e133.
[9]	魏瑶, 芦春花, 李岩. 全视野数字化乳腺摄影及数字乳腺断层摄影诊断致密型乳腺内病变[J]. 中国医学影像技术, 2018, 34(12):1815-1819.
[10]	代晓倩, 张伟. 数字乳腺断层摄影与超声对致密型乳腺内病变的诊断效能对比研究[J]. 中国医药, 2019, 14(5):738-741.
[11]	Sprague BL, Coley RY, Kerlikowske K, et al. Assessment of radiologist performance in breast cancer screening using digital breast tomosynthesis vs digital mammography[J]. AMA Netw Open, 2020, 3(3):e201759.
[12]	Whelehan P, Ali K, Vinnicombe S, et al. Digital breast tomosynthesis: sensitivity for cancer in younger symptomatic women[J]. Br J Radiol, 2021, 94(1119):20201105. doi: 10.1259/bjr.20201105 URL
[13]	Kim WH, Chang JM, Lee J, et al. Erratum to: Diagnostic performance of tomosynthesis and breast ultrasonography in women with dense breasts: a prospective comparison study[J]. Breast Cancer Res Treat, 2017, 163(1):197. doi: 10.1007/s10549-017-4172-1 URL
[14]	杨彩仙, 赵宏光, 刘慧, 等. 乳腺癌数字化X线三维断层摄影肿块边缘征象及其与病理学指标的相关性[J]. 肿瘤研究与临床, 2019, 31(1):16-21.
[15]	李弋, 叶兆祥, 吴涛, 等. 数字乳腺断层摄影与全数字化乳腺摄影对致密型乳腺病变诊断的初步对比研究[J]. 中华肿瘤杂志, 2013, 35(1):33-37.
[16]	Nakashima K, Uematsu T, Itoh T, et al. Comparison of visibility of circumscribed masses on Digital Breast Tomosynthesis (DBT) and 2D mammography: are circumscribed masses better visualized and assured of being benign on DBT?[J]. Eur Radiol, 2017, 27(2):570-577. doi: 10.1007/s00330-016-4420-5 pmid: 27236817
[17]	Partyka L, Lourenco AP, Mainiero MB. Detection of mammographically occult architectural distortion on digital breast tomosynthesis screening: initial clinical experie-nce[J]. AJR Am J Roentgenol, 2014, 203(1):216-222. doi: 10.2214/AJR.13.11047 URL
[18]	张晓飞. 数字化乳腺X线检查数字钼靶断层摄影及超声对致密型乳腺内病变诊断效能对比分析[J]. 中国药物与临床, 2019, 19(9),1438-1440.
[19]	Li J, Zhang H, Jiang H, et al. Diagnostic performance of digital breast tomosynthesis for breast suspicious calcifications from various populations: a comparison with full-field digital mammography[J]. Comput Struct Biotechnol J, 2018, 17:82-89. doi: 10.1016/j.csbj.2018.12.004 URL
[20]	李军涛, 郭旭辉, 田沛琦, 等. 数字乳腺三维断层摄影技术在乳腺可疑钙化型疾病中的诊断价值[J]. 中华普通外科杂志, 2018, 33(12):1042-1045.
[21]	Horvat JV, Keating DM, Rodrigues-Duarte H, et al. Calcifications at digital breast tomosynthesis: imaging features and biopsy techniques[J]. Radiographics, 2019, 39(2):307-318. doi: 10.1148/rg.2019180124 pmid: 30681901
[22]	Rochat CJ, Baird GL, Lourenco AP. Digital mammography stereotactic biopsy versus digital breast tomosynthesis-guided biopsy: differences in biopsy targets, pathologic results, and discordance rates[J]. Radiology, 2020, 294(3):518-527. doi: 10.1148/radiol.2019191525 pmid: 31961261
[23]	苏昆仑, 罗华, 杨欧欧, 等. 数字乳腺断层摄影在乳腺高危病灶中的诊断价值研究[J]. 浙江临床医学, 2019, 21(9):1182-1184.
[24]	Chand JT, Sharma MM, Dharmarajan JP, et al. Digital breast tomosynthesis as a tool in confirming negative surgical margins in non-palpable breast lesions[J]. Indian J Surg Oncol, 2019, 10(4):624-628. doi: 10.1007/s13193-019-00956-z URL
[25]	Girometti R, Marconi V, Linda A, et al. Preoperative assessment of breast cancer: Multireader comparison of contrast-enhanced MRI versus the combination of unenhanced MRI and digital breast tomosynthesis[J]. Breast, 2020, 49:174-182. doi: S0960-9776(19)31105-1 pmid: 31838292
[26]	Scott AM, Lashley MG, Drury NB, et al. Comparison of call-back rates between digital mammography and digital breast tomosynthesis[J]. Am Surg, 2019, 85(8):855-857.
[27]	Lowry KP, Trentham-Dietz A, Schechter CB, et al. Long-term outcomes and cost-effectiveness of breast cancer screening with digital breast tomosynthesis in the united states[J]. J Natl Cancer Inst, 2020, 112(6):582-589. doi: 10.1093/jnci/djz184 URL
[28]	Pujara AC, Hui J, Wang LC. Architectural distortion in the era of digital breast tomosynthesis: outcomes and implications for management[J]. Clin Imaging, 2019, 54:133-137. doi: 10.1016/j.clinimag.2019.01.004 URL
[29]	Geras KJ, Mann RM, Moy L. Artificial intelligence for mammography and digital breast tomosynthesis: current concepts and future perspectives[J]. Radiology, 2019, 293(2):246-259. doi: 10.1148/radiol.2019182627 URL
[30]	Conant EF, Toledano AY, Periaswamy S, et al. Improving accuracy and efficiency with concurrent use of artificial intelligence for digital breast tomosynthesis[J]. Radiol Artif Intell, 2019, 1(4):e180096.

数字乳腺体层合成在女性青年期乳腺癌筛查中的应用及研究进展

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 30

相关文章 15

编辑推荐

Metrics

本文评价

[1]	侯筱飒, 杨振江. 前哨淋巴结阳性乳腺癌患者发生非前哨淋巴结转移的危险因素分析[J]. 诊断学理论与实践, 2021, 20(03): 284-289.
[2]	卢叶君, 陈卉, 张剑, 徐斌, 王冲, 贺烨. 超微血管成像、超声弹性成像联合高频超声在微小乳腺癌中的诊断价值及相关高危超声特征的筛选[J]. 诊断学理论与实践, 2020, 19(04): 391-396.
[3]	罗婷, 周建桥. 超声新技术在预测乳腺癌分子标志物中的应用进展[J]. 诊断学理论与实践, 2020, 19(03): 325-328.
[4]	王志威, 张晓晓, 王杰, 魏敏, 邵玉国, 籍敏, 杨莉, 何奇. 局部晚期乳腺癌患者腋窝淋巴结转移范围的影响因素分析[J]. 诊断学理论与实践, 2019, 18(2): 189-192.
[5]	钟明, 赵峰, 吴衍, 裴文江, 高航, 郭善禹, 戴谦诚, 张伟. 血浆游离DNA中抑癌基因肿瘤高甲基化基因1甲基化检测方法的建立及其在乳腺疾病诊断中的意义[J]. 诊断学理论与实践, 2019, 18(2): 144-148.
[6]	裴文江, 赵峰, 吴衍, 钟明, 高航, 李幼生, 顾岩, 郭善禹, 戴谦诚, 张伟. 肿瘤高甲基化基因1重要下游基因HMMR对乳腺癌细胞株MDA-MB-231迁移和侵袭能力影响的体外实验[J]. 诊断学理论与实践, 2018, 17(01): 70-75.
[7]	许海敏, 张培培. 三款自动免疫组织化学染色仪在乳腺癌病理诊断中的应用比较[J]. 诊断学理论与实践, 2017, 16(06): 645-649.
[8]	吴衍, 丁佩芬, 顾岩, 郭善禹, 戴谦诚, 张伟. 乳腺癌肿瘤高甲基化基因1蛋白和透明质酸介导的细胞游走受体表达分析研究[J]. 诊断学理论与实践, 2017, 16(01): 73-78.
[9]	李畅, 方旭前, 卢煌莹, 顾志冬,. QKI-5在三阴乳腺癌组织中的表达及其意义[J]. 诊断学理论与实践, 2016, 15(02): 160-164.
[10]	高玉霞, 沈媛,. P53及nm23在不同分子亚型浸润性乳腺癌中的表达及意义[J]. 诊断学理论与实践, 2015, 14(01): 58-61.
[11]	褚庆华, 张婕, 孙奋勇,. miR-203调控NEDD9抑制乳腺癌细胞MDA-MB-231侵袭及迁移作用机制研究[J]. 诊断学理论与实践, 2014, 13(05): 505-510.
[12]	徐北惠, 梁璆荔, 倪培华,. 乳腺癌细胞自噬与相关miRNA研究进展[J]. 诊断学理论与实践, 2014, 13(04): 429-432.
[13]	曹静, 吕志排, 雷冬梅, 楚天骄, 郝志伟,. 乳腺癌的分子分型与临床病理特征及预后的关系[J]. 诊断学理论与实践, 2013, 12(04): 466-469.
[14]	张俊, 瞿晴, 费晓春, 陈小松, 任若冰, 徐昊平, 许赪, 沈坤炜,. 乳腺癌转移病灶再活检对于指导治疗的价值[J]. 诊断学理论与实践, 2013, 12(03): 304-308.
[15]	陆文汇, 吴瑛婷, 张贤华, 陈慧芬,. IGFBPs家族基因遗传变异与乳腺癌关系的研究进展[J]. 诊断学理论与实践, 2013, 12(01): 111-113.